Antimicrobial Peptides Against Antimicrobial-Resistant Bacteria: Focus on Machine Learning

Area of Science:

• Bioinformatics
• Computational Biology
• Drug Discovery

Background:

• Antimicrobial resistance (AMR) is a major global health threat, necessitating novel antibacterial strategies.
• Conventional drug pipelines are insufficient against emerging multidrug-resistant pathogens.
• Antimicrobial peptides (AMPs) show promise but discovering effective ones is challenging.

Purpose of the Study:

• To review advances in machine learning (ML) for antimicrobial peptide (AMP) discovery.
• To critically appraise computational methods for designing AMPs against resistant bacteria.
• To provide a roadmap for translating ML-designed AMPs to clinical application.

Main Methods:

• Review of machine learning algorithms (classical ML, deep learning, generative AI) for AMP modeling.
• Analysis of bioinformatics resources for peptide structure, activity, and interaction prediction.
• Discussion of advanced techniques like active learning and protein language models.

Main Results:

• ML enables rapid screening and de novo design of AMPs with optimized properties.
• Various ML models can predict peptide efficacy, safety, stability, and manufacturability.
• Current approaches show significant potential for discovering novel AMPs.

Conclusions:

• ML offers a powerful approach to overcome challenges in AMP discovery and engineering.
• Integrating ML into the discovery pipeline can accelerate the development of new antibiotics.
• Addressing challenges is crucial for the successful clinical translation of ML-designed AMPs.